Author: Philip M. Parker
Manufacturer: ICON Group International, Inc.
This study covers the latent demand outlook for systemic antibiotic-sulfonamide combination pharmaceuticals across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin),
special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as "regions"). Latent demand (in millions of U.S. dollars), or
potential industry earnings (P.I.E.) estimates are given across some 1, 100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as…
